Humana Inc Etf Price To Sales
| HUM Etf | USD 298.11 2.40 0.81% |
Humana Inc fundamentals help investors to digest information that contributes to Humana's financial success or failures. It also enables traders to predict the movement of Humana Etf. The fundamental analysis module provides a way to measure Humana's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Humana etf.
Humana |
Humana Inc ETF Price To Sales Analysis
Humana's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Humana Price To Sales | 0.31 X |
Most of Humana's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humana Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Humana Inc has a Price To Sales of 0.3121 times. This is much higher than that of the Health Care Providers & Services family and significantly higher than that of the Health Care category. The price to sales for all United States etfs is notably lower than that of the firm.
Humana Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humana's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Humana could also be used in its relative valuation, which is a method of valuing Humana by comparing valuation metrics of similar companies.Humana is currently under evaluation in price to sales as compared to similar ETFs.
Humana ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Humana's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Humana's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Humana Fundamentals
| Return On Equity | 0.0784 | ||||
| Return On Asset | 0.0401 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 43.8 B | ||||
| Shares Outstanding | 120.41 M | ||||
| Shares Owned By Insiders | 0.21 % | ||||
| Shares Owned By Institutions | 94.77 % | ||||
| Number Of Shares Shorted | 4.38 M | ||||
| Price To Earning | 19.12 X | ||||
| Price To Book | 2.04 X | ||||
| Price To Sales | 0.31 X | ||||
| Revenue | 106.37 B | ||||
| Gross Profit | 17.18 B | ||||
| EBITDA | 4.93 B | ||||
| Net Income | 2.49 B | ||||
| Cash And Equivalents | 5.06 B | ||||
| Cash Per Share | 143.73 X | ||||
| Total Debt | 11.66 B | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 1.53 X | ||||
| Book Value Per Share | 145.88 X | ||||
| Cash Flow From Operations | 3.98 B | ||||
| Short Ratio | 1.20 X | ||||
| Earnings Per Share | 11.45 X | ||||
| Price To Earnings To Growth | 1.37 X | ||||
| Target Price | 288.15 | ||||
| Number Of Employees | 67.6 K | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 35.9 B | ||||
| Total Asset | 47.06 B | ||||
| Retained Earnings | 27.54 B | ||||
| Working Capital | 366.27 M | ||||
| Current Asset | 2.76 B | ||||
| Current Liabilities | 2.39 B | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.64 % | ||||
| Net Asset | 47.06 B | ||||
| Last Dividend Paid | 3.54 |
About Humana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humana Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana Inc based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.